Unilever plc (UL US)
UL US$64.18
20 minute delayed
14 days free access
Join Market Matters and get full access to all our Opinion + Action
Performance
Advanced charting functionality with the ability to amend timeframes, chart type & indicator selection, powered by TradingView.
Share price activity
Displays share price activity. Volume = number of shares traded, Turnover = value of shares traded, VWAP = volume-weighted average price for the day, sourced from Morningstar.
- Last (Price)
- 64.18
- Change
- ▲ 0.24 (0.38)
- Bid / Ask
- 64.18 - 64.18
- Volume
- 644,096
- Turnover
- 35,367,038
- Open
- 64.35
- Day Range
- 63.78 - 64.65
- VWAP
- 64.14
- Prev Close
- 63.94
- Last Trade
- 29/10 4:10pm
Key information
Displays key information on the security, sourced from Morningstar.
- Sector
- Consumer Defensive
- Shares Issued
- 2,154,327,953
- NTA/Share
- -7.88
- Last Dividend
- 0.53
- Dividend Ex Date
- 7 AUG 2026
- Dividend Pay Date
- 18 SEP 2026
Current (EUR) · FY2025
Displays key financial data for the most recent fiscal year, in millions. Note - Per share data is in local currency terms irrespective of reporting currency, and may be different to the stated currency, sourced from Morningstar.
- Revenue
- 50,503.00
- EBITDA
- 10,672.00
- Profit
- 9,469.00
- Earnings Per Share (EPS)
- 4.32
- Dividend Per Share (DPS)
- 1.82
- Yield %
- 3.47
- Market Cap
- 138,214.14
- Price to Earnings Ratio (P/E)
- 22.55
Estimates (EUR) · FY2027
Displays consensus analyst’s estimates for key measures for the next fiscal year, sourced from Morningstar.
- Revenue
- 52,231.34
- EBITDA
- 11,566.33
- Profit
- 6,778.18
- Earnings Per Share (EPS)
- 3.41
- Dividend Per Share (DPS)
- 1.85
Quantitative rating
Displays Morningstar’s Quantitative Equity Research Rating for the security: a star rating from 1 (overvalued) to 5 (undervalued) from the share price against a fair value estimated by a statistical model of Morningstar’s analyst ratings, with the model’s economic moat, financial health and fair value uncertainty, sourced from Morningstar.
Undervalued
- Economic Moat
- Wide
- Financial Health
- Strong
- Uncertainty
- Medium
Morningstar Quantitative Rating as of 28 OCT 2026.
Quantitative Equity Rating Methodology – view here
Fair value estimate
Displays Morningstar’s quantitative fair value estimate for the security against the current share price, with the band around it: the five-star price below which the model would rate the stock five stars and the one-star price above which it would rate it one star, sourced from Morningstar.
Five-star price 65.39 Fair value 73.15 One-star price 81.82
Morningstar Quantitative Rating as of 28 OCT 2026.
Quantitative valuation
Displays where the share price sits in Morningstar’s quantitative fair value band, from the five-star price (undervalued) to the one-star price (overvalued), with the fair value estimate, the price to fair value ratio, the model’s valuation label and its uncertainty rating, sourced from Morningstar.
Buy
Sell
- Fair Value
- 73.15
- Price / Fair Value
- 0.87
- Valuation
- Undervalued
- Uncertainty
- Medium
Morningstar Quantitative Rating as of 28 OCT 2026. The slider runs from the five-star price (65.39) to the one-star price (81.82).
Displays useful ratios for the security, NB the pricing date used, sourced from Morningstar.
| Ratios |
|---|
| Currency (Price/reporting): USD/EUR |
| Exchange Rate: 1.1130 |
Price, volume and trading statistics for the security, sourced from Morningstar.
| Price - closing or last bid | 63.94 |
| Price - 12 month high | 74.97 |
| Price - 12 month low | 54.75 |
| Pricing date | 27 OCT 2026 |
| Volume - avg. trading volume for the last ten days | 3.81 |
| Market capitalization | 137,697.29 |
| 12 Month High price date | 13 FEB 2026 |
| 12 Month Low price date | 4 JUN 2026 |
| Volume - avg. trading volume for the last 3 months | 3.80 |
| Price - 1 Day % Change | -1.71% |
| Price - 13 week price percent change | -4.38% |
| Price - 26 week price percent change | 10.83% |
| Price - 5 Day % Change | -0.71% |
| Price - 52 week price percent change | -8.21% |
| Price - YTD price percent change | -2.56% |
| Price % Change Month To Date | 2.25% |
Earnings, dividends, cash flow and book value per share, sourced from Morningstar.
| EPS excluding extraordinary items - most recent fiscal year | 2.590 |
| EPS excluding extraordinary items - trailing 12 month | 4.241 |
| EPS Normalized - most recent fiscal year | 3.080 |
| Revenue/share - most recent fiscal year | 23.005 |
| Revenue/share - trailing 12 month | 21.032 |
| Book value per share - most recent fiscal year | 7.126 |
| Book value per share - most recent quarter | 7.521 |
| Book value (tangible) per share - most recent fiscal year | -7.881 |
| Book value (tangible) per share - most recent quarter | -8.252 |
| Cash per share - most recent fiscal year | 1.808 |
| Cash per share - most recent quarter | 2.195 |
| Cash Flow per share - most recent fiscal year | 3.151 |
| Cash Flow per share - trailing 12 month | 2.658 |
| Dividend per share - most recent fiscal year | 1.820 |
| Dividends per share - trailing 12 month | 2.222 |
| EBITD per share - trailing 12 month | 4.297 |
| EPS Basic excluding extraordinary items - most recent fiscal year | 2.600 |
| EPS Basic excluding extraordinary items - trailing 12 month | 4.241 |
| EPS including extraordinary items - most recent fiscal year | 4.330 |
| EPS including extraordinary items - trailing 12 month | 4.241 |
| Free Cash Flow per share - trailing 12 month | 1.994 |
Valuation multiples such as P/E, price to sales, price to book and enterprise value ratios, sourced from Morningstar.
| P/E excluding extraordinary items, most recent fiscal year | 12.92 |
| P/E Normalized, most recent fiscal year | 12.72 |
| Price to sales - most recent fiscal year | 2.61 |
| Price to Tangible Book - most fiscal year | — |
| Price to Free Cash Flow per Share - most recent fiscal year | 27.49 |
| Price to Cash Flow per share - trailing 12 month | 20.62 |
| Price to Book - most recent fiscal year | 7.45 |
| P/E excluding extraordinary items high, trailing 12 months | 26.75 |
| P/E excluding extraordinary items low, trailing 12 months | 12.04 |
| Net Debt, LFI | 26,239.00 |
| Net Debt, LFY | 22,344.00 |
| Dividend Yield - 5 Year Average | 3.54% |
| Dividend Yield - indicated annual dividend divided by closing price | 3.42% |
| Current Dividend Yield - Common Stock Primary Issue, LTM | 3.47% |
Cash flow, liquidity and leverage measures, sourced from Morningstar.
| Free Cash Flow - most recent fiscal year | 5,327.00 |
| LT debt/equity - most recent fiscal year | 142.95% |
| Payout ratio - most recent fiscal year | 42.13% |
| Total debt/total equity - most recent fiscal year | 156.92% |
| LT debt/equity - most recent quarter | 0.00% |
| Total debt/total equity - most recent quarter | 175.40% |
| Free Cash Flow - trailing 12 month | 4,361.00 |
| Payout ratio - trailing 12 month | — |
Key income statement lines for the most recent fiscal year, in millions, sourced from Morningstar.
| Revenue - most recent fiscal year | 50,503.00 |
| Revenue - trailing 12 month | 45,999.00 |
| EBITD - most recent fiscal year | 10,672.00 |
| EBITD - trailing 12 month | 9,398.00 |
| Earnings before taxes - most recent fiscal year | 8,693.00 |
| Earnings before taxes - trailing 12 month | 8,259.00 |
| Net Income available to common - most recent fiscal year | 9,469.00 |
| Net Income available to common - trailing 12 months | 9,273.00 |
| Earnings before taxes Normalized - most recent fiscal year | 9,995.00 |
| Net Income Available to Common, Normalized - most recent fiscal year | 6,761.00 |
| Earnings per Share, Normalized, Excluding Extraordinary Items, Avg. Diluted Shares Outstanding, TTM | 4.31 |
Profitability margins for the most recent fiscal year, sourced from Morningstar.
| Net Profit Margin % - 1st historical fiscal year | 12.30% |
| Net Profit Margin % - trailing 12 month | — |
| Operating margin - 1st historical fiscal year | 20.05% |
| Operating margin - trailing 12 month | — |
| Pretax margin - trailing 12 month | 17.95% |
| Pretax margin - 1st historical fiscal year | 17.21% |
| Operating Margin - 5 year average | 18.43% |
| Pretax Margin - 5 year average | 16.68% |
| Free Operating Cash Flow/Revenue, 5 Year Average | 11.04% |
| Free Operating Cash Flow/Revenue, TTM | 9.48% |
| Net Profit Margin - 5 year average | 12.61% |
Returns on average assets and equity for the fiscal year, the trailing 12 months and as 5 year averages, and net income and revenue per employee in whole currency, sourced from Morningstar.
| Return on average assets - most recent fiscal year | 8.24% |
| Return on average assets - trailing 12 month | — |
| Return on average equity - most recent fiscal year | 34.96% |
| Return on average equity - trailing 12 month | — |
| Return on average assets - 5 year average | — |
| Return on average equity - 5 year average | — |
| Net Income/employee - most recent fiscal year | 64,656.79 |
| Revenue/employee - most recent fiscal year | 525,569.25 |
Growth in revenue, earnings, dividends and book value over recent periods, sourced from Morningstar.
| Revenue growth rate, 5 year | -0.09% |
| EPS growth rate, 5 year | 12.62% |
| Growth rate% - dividend, 3 year | 3.14% |
| Revenue/share (5 yr growth) | 1.18% |
| Growth rate% - Revenue, 3 year | -5.62% |
| Growth rate% - EPS, 3 year | 8.70% |
| Book value per share growth rate, 5 year | 1.74% |
| Capital Spending growth rate, 5 year | 9.28% |
| Earnings Before Interest, Taxes, Depreciation & Amortization, 5 Year CAGR | 0.35% |
Displays analyst’s forecasts for key measures. The estimates can be expanded to see the spread of the calls. Full lines = reported, and dotted lines are forward estimates. Click a measure to add or remove it from the chart, sourced from Morningstar.
Financial forecast (EUR, millions except per share)
| Actuals | Estimates | |||||||
| 2025 | 2026 | 2027 | 2028 | 2029 | ||||
| Estimate breakdown | ||||||||
Financial metrics can be plotted on the graph to see trends. Multiple metrics from multiple statements can be plotted against each other, sourced from Morningstar.
Financials (EUR, millions)
| Period end: | DEC 21 | DEC 22 | DEC 23 | DEC 24 | DEC 25 |
| Fiscal year: | 2021 | 2022 | 2023 | 2024 | 2025 |
| Period length: | 12 months | 12 months | 12 months | 12 months | 12 months |
Displays all company announcements released by the company to the exchange, sourced from Morningstar.
Announcements
Announcements are available for ASX-listed companies only.
Opinion
No opinions for this company yet.
Action
No actions for this company yet.
Business Summary
Unilever is a diversified beauty, well-being, and personal care (51% of 2025 sales by value), homecare (23%), and packaged food (26%) company. Its brands include Dove personal-care products, Knorr soups and sauces, Hellmann's mayonnaise, Axe and Rexona deodorants, and TRESemme haircare. The firm has been acquisitive in recent years; notable purchases include Paula's Choice, Liquid I.V., Horlicks, and Wild deodorants. The company derives 58% of its sales from emerging marketsand 42% from developed markets. The US is its largest market, accounting for around 20% of sales, followed by India, which accounts for 11% of sales.
Relevant suggested news and content from the site
Video
WATCH
Webinar Recording: Are commodities entering a Supercycle?
Recorded Wednesday 24th June @ 12.30pm
Podcast
LISTEN
Thursday 11th September – Dow off -220pts, SPI off -20pts
Daily Podcast Direct from the Desk
Video
WATCH
Buy Hold Sell: The 6 income stocks readers love, plus 2 expert ideas
Recorded 10th June 2026
Podcast
LISTEN
Wednesday 10th September – Dow up +196pts, SPI down -4pts
Daily Podcast Direct from the Desk
